APA (7th ed.) Citation

Arranz-Nicolás, J., Martin-Salgado, M., Adán-Barrientos, I., Liébana, R., del Carmen Moreno-Ortíz, M., Leitner, J., . . . Merida, I. (2021). Diacylglycerol kinase α inhibition cooperates with PD-1-targeted therapies to restore the T cell activation program. Cancer Immunology, Immunotherapy, 70(11), 3277. https://doi.org/10.1007/s00262-021-02924-5

Chicago Style (17th ed.) Citation

Arranz-Nicolás, Javier, Miguel Martin-Salgado, Irene Adán-Barrientos, Rosa Liébana, María del Carmen Moreno-Ortíz, Judith Leitner, Peter Steinberger, Antonia Ávila-Flores, and Isabel Merida. "Diacylglycerol Kinase α Inhibition Cooperates with PD-1-targeted Therapies to Restore the T Cell Activation Program." Cancer Immunology, Immunotherapy 70, no. 11 (2021): 3277. https://doi.org/10.1007/s00262-021-02924-5.

MLA (9th ed.) Citation

Arranz-Nicolás, Javier, et al. "Diacylglycerol Kinase α Inhibition Cooperates with PD-1-targeted Therapies to Restore the T Cell Activation Program." Cancer Immunology, Immunotherapy, vol. 70, no. 11, 2021, p. 3277, https://doi.org/10.1007/s00262-021-02924-5.